跳至主要内容
临床试验/NCT01209806
NCT01209806已完成不适用

The Effects of Moviprep With Simethicone on Colonic Bubbles

Thomas Jefferson University1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2009年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
140
试验地点
1
主要终点
Efficacy - Entire colon

研究概览

简要总结

The purpose of this study is to determine whether the administration of PEG along with simethicone will reduce the incidence of colonic bubbles that interfere with polyp detection.

详细描述

evaluating if simethicone is better than placebo at decreasing gas in the colon at time of colonoscopy so that it is easier for the endoscopist to see polyps

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Elective outpatients undergoing colonoscopy using split dose PEG-ELS with sodium ascorbate and ascorbic acid

排除标准

  • Unable or unwilling to give informed consent
  • Age < 18 years
  • Breast feeding
  • Established or suspected gastroparesis
  • Pseudo-obstruction - established or suspected
  • Severe constipation (< 1 BM a week)
  • Bowel obstruction
  • Greater than 50% resection of colon
  • Chronic nausea or vomiting
  • Consumed > 100% standard dose of PEG-ELS (i.e. more than 2L)
  • G6PD deficiency
  • PEG allergy
  • Significant psychiatric illness

研究组 & 干预措施

simethicone

Active Comparator

干预措施: simethicone (Drug)

结局指标

主要结局

Efficacy - Entire colon

时间窗: At time of colonoscopy

Successful cleansing defined as score or excellent or good Unsuccessful cleansing defined as score of fair or inadequate

次要结局

  • Efficacy - Right colon(At time of colonoscopy)
  • Adenoma detection(at time of colonoscopy)
  • Flushing(at time of colonoscopy)
  • Tolerance(during prep ingestion)
  • Safety(at time of colonoscopy)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验